
Sudhakar Katakam
Examiner (ID: 1906, Phone: (571)272-9929 , Office: P/1671 )
| Most Active Art Unit | 1658 |
| Art Unit(s) | 1676, 1658, 1621, 1671 |
| Total Applications | 1838 |
| Issued Applications | 1259 |
| Pending Applications | 128 |
| Abandoned Applications | 477 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 11554234
[patent_doc_number] => 20170100481
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-04-13
[patent_title] => 'TRANSDERMAL PHARMACEUTICAL COMPOSITIONS WITH REDUCED SKIN IRRITATION'
[patent_app_type] => utility
[patent_app_number] => 15/287976
[patent_app_country] => US
[patent_app_date] => 2016-10-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 6131
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15287976
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/287976 | TRANSDERMAL PHARMACEUTICAL COMPOSITIONS WITH REDUCED SKIN IRRITATION | Oct 6, 2016 | Abandoned |
Array
(
[id] => 19025860
[patent_doc_number] => 11925197
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-03-12
[patent_title] => Beta-caseins and gut microbiota
[patent_app_type] => utility
[patent_app_number] => 16/333939
[patent_app_country] => US
[patent_app_date] => 2016-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4956
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16333939
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/333939 | Beta-caseins and gut microbiota | Sep 29, 2016 | Issued |
Array
(
[id] => 13489923
[patent_doc_number] => 20180296504
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-10-18
[patent_title] => Novel Antioxidizing Intraocular Perfusion Solution
[patent_app_type] => utility
[patent_app_number] => 15/762726
[patent_app_country] => US
[patent_app_date] => 2016-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4785
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 101
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15762726
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/762726 | Antioxidizing intraocular perfusion solution | Sep 29, 2016 | Issued |
Array
(
[id] => 11382843
[patent_doc_number] => 20170008900
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-01-12
[patent_title] => 'BICYCLIC COMPOUNDS AS AUTOTAXIN (ATX) AND LYSOPHOSPHATIDIC ACID (LPA) PRODUCTION INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 15/272114
[patent_app_country] => US
[patent_app_date] => 2016-09-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23815
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15272114
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/272114 | Bicyclic compounds as autotaxin (ATX) and lysophosphatidic acid (LPA) production inhibitors | Sep 20, 2016 | Issued |
Array
(
[id] => 11894000
[patent_doc_number] => 09763919
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-09-19
[patent_title] => 'Detecting and treating growth hormone deficiency'
[patent_app_type] => utility
[patent_app_number] => 15/271542
[patent_app_country] => US
[patent_app_date] => 2016-09-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 8
[patent_no_of_words] => 9308
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15271542
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/271542 | Detecting and treating growth hormone deficiency | Sep 20, 2016 | Issued |
Array
(
[id] => 11521523
[patent_doc_number] => 09604908
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-03-28
[patent_title] => 'Diether based biodegradable cationic lipids for siRNA delivery'
[patent_app_type] => utility
[patent_app_number] => 15/269197
[patent_app_country] => US
[patent_app_date] => 2016-09-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12936
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15269197
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/269197 | Diether based biodegradable cationic lipids for siRNA delivery | Sep 18, 2016 | Issued |
Array
(
[id] => 13425161
[patent_doc_number] => 20180264123
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-09-20
[patent_title] => LONG-ACTING ADRENOMEDULLIN DERIVATIVE
[patent_app_type] => utility
[patent_app_number] => 15/760310
[patent_app_country] => US
[patent_app_date] => 2016-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32765
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15760310
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/760310 | Long-acting adrenomedullin derivative | Sep 15, 2016 | Issued |
Array
(
[id] => 16642099
[patent_doc_number] => 10919935
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-02-16
[patent_title] => Antimicrobial peptide derived from myxinidin peptide and uses thereof
[patent_app_type] => utility
[patent_app_number] => 15/757793
[patent_app_country] => US
[patent_app_date] => 2016-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 15
[patent_no_of_words] => 12080
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15757793
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/757793 | Antimicrobial peptide derived from myxinidin peptide and uses thereof | Sep 11, 2016 | Issued |
Array
(
[id] => 13674993
[patent_doc_number] => 20160376230
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-12-29
[patent_title] => UREA GRANULATION PROCESS WITH SCRUBBING SYSTEM
[patent_app_type] => utility
[patent_app_number] => 15/260018
[patent_app_country] => US
[patent_app_date] => 2016-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4650
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 136
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15260018
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/260018 | Urea granulation process with scrubbing system | Sep 7, 2016 | Issued |
Array
(
[id] => 15882825
[patent_doc_number] => 10647744
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-05-12
[patent_title] => Tripeptide epoxy ketone protease inhibitors
[patent_app_type] => utility
[patent_app_number] => 15/251688
[patent_app_country] => US
[patent_app_date] => 2016-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 58976
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 284
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15251688
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/251688 | Tripeptide epoxy ketone protease inhibitors | Aug 29, 2016 | Issued |
Array
(
[id] => 13297373
[patent_doc_number] => 20180200223
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-07-19
[patent_title] => APPLICATION OF NARINGENIN AND NARINGIN IN TUMOR RADIOTHERAPY
[patent_app_type] => utility
[patent_app_number] => 15/743288
[patent_app_country] => US
[patent_app_date] => 2016-08-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4261
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15743288
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/743288 | Application of naringenin and naringin in tumor radiotherapy | Aug 24, 2016 | Issued |
Array
(
[id] => 11336605
[patent_doc_number] => 20160362360
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-12-15
[patent_title] => 'UREA PRODUCTION PLANT'
[patent_app_type] => utility
[patent_app_number] => 15/246334
[patent_app_country] => US
[patent_app_date] => 2016-08-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 5231
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15246334
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/246334 | Urea production plant | Aug 23, 2016 | Issued |
Array
(
[id] => 11755925
[patent_doc_number] => 20170202792
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-07-20
[patent_title] => 'METHOD FOR TREATING TAU-ASSOCIATED DISEASES'
[patent_app_type] => utility
[patent_app_number] => 15/238048
[patent_app_country] => US
[patent_app_date] => 2016-08-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 5826
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15238048
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/238048 | METHOD FOR TREATING TAU-ASSOCIATED DISEASES | Aug 15, 2016 | Abandoned |
Array
(
[id] => 13589939
[patent_doc_number] => 20180346518
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-12-06
[patent_title] => LYSOBACTIN FOR USE IN THE TREATMENT OF BOVINE MASTITIS
[patent_app_type] => utility
[patent_app_number] => 15/752936
[patent_app_country] => US
[patent_app_date] => 2016-08-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4148
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15752936
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/752936 | LYSOBACTIN FOR USE IN THE TREATMENT OF BOVINE MASTITIS | Aug 15, 2016 | Abandoned |
Array
(
[id] => 11823188
[patent_doc_number] => 20170212125
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-07-27
[patent_title] => 'PEPTIDOMIMETIC MACROCYCLES WITH IMPROVED PROPERTIES'
[patent_app_type] => utility
[patent_app_number] => 15/233796
[patent_app_country] => US
[patent_app_date] => 2016-08-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 27
[patent_no_of_words] => 26587
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15233796
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/233796 | PEPTIDOMIMETIC MACROCYCLES WITH IMPROVED PROPERTIES | Aug 9, 2016 | Abandoned |
Array
(
[id] => 11311594
[patent_doc_number] => 20160347704
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-12-01
[patent_title] => 'PHOTOLABILE PRO-FRAGRANCES'
[patent_app_type] => utility
[patent_app_number] => 15/232125
[patent_app_country] => US
[patent_app_date] => 2016-08-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8508
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15232125
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/232125 | Photolabile pro-fragrances | Aug 8, 2016 | Issued |
Array
(
[id] => 12363999
[patent_doc_number] => 09956192
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-05-01
[patent_title] => Selective histone deactylase 6 inhibitors
[patent_app_type] => utility
[patent_app_number] => 15/231187
[patent_app_country] => US
[patent_app_date] => 2016-08-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 38
[patent_figures_cnt] => 38
[patent_no_of_words] => 18276
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 231
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15231187
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/231187 | Selective histone deactylase 6 inhibitors | Aug 7, 2016 | Issued |
Array
(
[id] => 11435977
[patent_doc_number] => 20170036992
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-02-09
[patent_title] => 'BETA-SUBSTITUTED BETA-AMINO ACIDS AND ANALOGS AS CHEMOTHERAPEUTIC AGENTS AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 15/227237
[patent_app_country] => US
[patent_app_date] => 2016-08-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 31
[patent_figures_cnt] => 31
[patent_no_of_words] => 178938
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15227237
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/227237 | Beta-substituted beta-amino acids and analogs as chemotherapeutic agents and uses thereof | Aug 2, 2016 | Issued |
Array
(
[id] => 11290339
[patent_doc_number] => 20160340271
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-11-24
[patent_title] => 'METHODS FOR PREPARATION OF LYCOPENES FROM C15-WITTIG SALTS AND METHODS FOR PURIFICATION OF HIGH ALL-E CONTAINING AND HIGH 6Z CONTAINING C15-WITTIG SALTS'
[patent_app_type] => utility
[patent_app_number] => 15/227343
[patent_app_country] => US
[patent_app_date] => 2016-08-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4254
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15227343
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/227343 | METHODS FOR PREPARATION OF LYCOPENES FROM C15-WITTIG SALTS AND METHODS FOR PURIFICATION OF HIGH ALL-E CONTAINING AND HIGH 6Z CONTAINING C15-WITTIG SALTS | Aug 2, 2016 | Abandoned |
Array
(
[id] => 11436004
[patent_doc_number] => 20170037025
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-02-09
[patent_title] => 'Muscarinic Agonists'
[patent_app_type] => utility
[patent_app_number] => 15/227325
[patent_app_country] => US
[patent_app_date] => 2016-08-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 43847
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15227325
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/227325 | Muscarinic agonists | Aug 2, 2016 | Issued |